This is not the most recent version of this material.
For an updated version, please see the relevant topic page.
Cystic Fibrosis: Stakeholder List
ICER has identified the organizations included on this list as key stakeholders for its upcoming report on modulator treatments for Cystic Fibrosis. ICER will invite input from these organizations, and welcomes suggestions from the broader community on additional organizations to add to this list. ICER often receives comments from individual patients and clinicians, and invites the public to submit recommendations for key stakeholders in these categories.View All Materials on this Topic or Go Back to View More Materials